Advice on newborn blood spot testing for SCID
Intended for healthcare professionals
Opinion Previous     Next

Advice on newborn blood spot testing for SCID

Erin Dean Health writer

Screening for severe combined immunodeficiency is being tested as part of a newborn blood spot testing programme

Severe combined immunodeficiency (SCID) is a is a group of rare inherited conditions that impair the development of the immune system, leading to reduced numbers of and malfunctioning T and B lymphocytes, which are white blood cells made in the bone marrow and thymus gland to fight infection. This means that illnesses that are not serious for most babies can be life-threatening for infants with SCID. Without early recognition and treatment, babies with SCID generally die before one year of age.

Nursing Children and Young People. 33, 6, 16-17. doi: 10.7748/ncyp.33.6.16.s7

Want to read more?

Already subscribed? Log in


Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now